Proto-oncogene PIM-1 is a novel estrogen receptor target associating with high grade breast tumors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Proto-oncogene PIM-1 is a novel estrogen receptor target associating with high grade breast tumors

Published:2013-01 Issue:2 Volume:365 Page:270-276
ISSN:0303-7207
Container-title:Molecular and Cellular Endocrinology
language:en
Short-container-title:Molecular and Cellular Endocrinology

Author:

Malinen Marjo,Jääskeläinen Tiina,Pelkonen Mikko,Heikkinen Sami,Väisänen Sami,Kosma Veli-Matti,Nieminen Kaisa,Mannermaa Arto,Palvimo Jorma J.

Publisher

Elsevier BV

Subject

Endocrinology,Molecular Biology,Biochemistry

Reference46 articles.

1. Pim-1 kinase promotes inactivation of the pro-apoptotic bad protein by phosphorylating it on the Ser112 gatekeeper site;Aho;FEBS Lett.,2004

2. Antiestrogens and their therapeutic applications in breast cancer and other diseases;Ali;Annu. Rev. Med.,2011

3. The human protooncogene product p33pim is expressed during fetal hematopoiesis and in diverse leukemias;Amson;Proc. Natl. Acad. Sci. USA,1989

4. Identification of tumor-associated autoantigens for the diagnosis of colorectal cancer in serum using high density protein microarrays;Babel;Mol. Cell. Proteomics,2009

5. Batra, V., Maris, J.M., Kang, M.H., Reynolds, C.P., Houghton, P.J., Alexander, D., Kolb, E.A., Gorlick, R., Keir, S.T., Carol, H., Lock, R., Billups, C.A., Smith, M.A. 2011. Initial testing (stage 1) of SGI-1776, a PIM1 kinase inhibitor, by the pediatric preclinical testing program. Pediatr. Blood Cancer.

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Macrocyclization strategy for improving candidate profiles in medicinal chemistry;European Journal of Medicinal Chemistry;2024-06

2. Integrative modeling uncovers p21-driven drug resistance and prioritizes therapies for PIK3CA-mutant breast cancer;npj Precision Oncology;2024-01-26

3. Photoinduced electron transfer (PeT) based fluorescent probes for cellular imaging and disease therapy;Chemical Society Reviews;2023

4. Antitumor activity of the protein kinase inhibitor 1-(β-D-2′-deoxyribofuranosyl)-4,5,6,7-tetrabromo- 1H-benzimidazole in breast cancer cell lines;BMC Cancer;2022-10-15

5. Design, synthesis, and bioactivity evaluation of macrocyclic benzo[b]pyrido[4,3-e][1,4]oxazine derivatives as novel Pim-1 kinase inhibitors;Bioorganic & Medicinal Chemistry Letters;2022-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3